NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
1.81
Dollar change
+0.06
Percentage change
3.43
%
IndexRUT P/E- EPS (ttm)-1.51 Insider Own13.11% Shs Outstand48.31M Perf Week-4.23%
Market Cap87.44M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float41.98M Perf Month-11.27%
Enterprise Value-29.89M PEG- EPS next Q- Inst Own32.96% Short Float19.58% Perf Quarter9.70%
Income-72.79M P/S- EPS this Y62.33% Inst Trans-8.18% Short Ratio7.25 Perf Half Y-22.65%
Sales0.00M P/B0.69 EPS next Y- ROA-49.07% Short Interest8.22M Perf YTD-23.31%
Book/sh2.64 P/C0.75 EPS next 5Y- ROE-70.59% 52W High42.20 -95.71% Perf Year-90.25%
Cash/sh2.43 P/FCF- EPS past 3/5Y-21.17% -40.61% ROIC-57.04% 52W Low1.15 57.39% Perf 3Y-94.12%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility4.85% 4.97% Perf 5Y-35.36%
Dividend TTM- EV/Sales- EPS Y/Y TTM-30.52% Oper. Margin- ATR (14)0.11 Perf 10Y-85.39%
Dividend Ex-DateDec 13, 2012 Quick Ratio9.08 Sales Y/Y TTM- Profit Margin- RSI (14)39.40 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio9.08 EPS Q/Q-14.07% SMA20-10.79% Beta-2.06 Target Price2.00
Payout- Debt/Eq0.00 Sales Q/Q- SMA50-4.35% Rel Volume0.94 Prev Close1.75
Employees30 LT Debt/Eq0.00 EarningsMay 08 BMO SMA200-79.85% Avg Volume1.13M Price1.81
IPOJul 14, 2000 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume1,067,063 Change3.43%
Date Action Analyst Rating Change Price Target Change
Nov-26-24Downgrade H.C. Wainwright Buy → Neutral
Oct-08-24Upgrade H.C. Wainwright Neutral → Buy $116
Jul-01-24Downgrade H.C. Wainwright Buy → Neutral
Nov-16-22Downgrade B. Riley Securities Buy → Neutral $44
Jul-15-21Downgrade Cantor Fitzgerald Overweight → Neutral $100
Jul-07-21Reiterated Maxim Group Buy $80 → $190
Apr-27-21Initiated B. Riley Securities Buy $78
Feb-16-21Reiterated H.C. Wainwright Buy $20 → $66
Oct-23-20Initiated Cantor Fitzgerald Overweight $24
Sep-23-20Upgrade H.C. Wainwright Neutral → Buy $20
Today 07:00AM
May-08-25 08:00AM
May-01-25 07:30AM
07:30AM
Apr-21-25 04:30PM
09:35AM Loading…
Apr-01-25 09:35AM
Mar-31-25 10:00AM
Mar-26-25 10:02AM
07:43AM
Mar-25-25 08:05AM
Mar-20-25 06:18PM
Mar-05-25 11:20AM
Mar-03-25 07:30AM
Feb-27-25 07:00AM
Jan-16-25 01:56PM
12:15PM Loading…
Jan-13-25 12:15PM
Jan-07-25 04:30PM
Dec-27-24 05:45AM
Dec-16-24 02:55PM
Nov-25-24 04:15PM
03:57PM
09:19AM
07:30AM
Nov-24-24 08:01PM
Nov-18-24 08:30AM
Nov-07-24 07:55AM
Oct-31-24 08:30AM
Oct-17-24 09:19PM
Oct-09-24 08:29AM
Sep-27-24 03:36PM
10:10AM Loading…
10:10AM
Sep-26-24 06:15PM
Sep-24-24 08:30AM
Sep-09-24 08:30AM
Sep-03-24 08:31AM
Aug-17-24 10:44PM
08:22AM
Aug-08-24 08:00AM
Aug-06-24 10:00AM
Aug-05-24 09:01AM
Aug-01-24 08:30AM
Jul-30-24 08:15AM
Jul-17-24 12:26PM
08:00AM
Jul-08-24 04:45PM
Jul-05-24 07:30AM
Jul-04-24 07:47AM
Jul-01-24 03:54PM
01:30PM
11:20AM
10:40AM
Jun-28-24 06:14PM
03:58PM
Jun-27-24 03:38PM
May-23-24 09:55AM
May-10-24 08:53PM
04:02PM
May-08-24 11:00AM
May-01-24 09:10AM
Apr-30-24 01:16PM
Apr-15-24 09:20AM
Mar-25-24 09:13AM
Mar-13-24 10:45AM
Mar-04-24 09:15AM
Feb-28-24 09:14AM
Feb-23-24 11:30AM
Feb-08-24 10:39AM
Feb-07-24 09:08AM
Feb-05-24 02:35PM
Jan-05-24 11:46AM
09:12AM
Dec-26-23 05:06AM
Dec-15-23 06:06PM
Dec-13-23 11:10AM
Dec-12-23 02:02PM
09:13AM
Dec-08-23 07:31PM
Dec-07-23 04:01PM
Nov-14-23 09:53PM
Nov-07-23 09:39AM
09:01AM
Nov-06-23 09:15AM
Oct-31-23 08:15AM
Oct-25-23 09:15AM
Oct-19-23 09:59AM
Oct-16-23 07:01PM
05:26PM
Oct-13-23 03:29PM
03:29PM
12:45PM
11:21AM
Oct-12-23 11:43PM
Oct-06-23 03:13PM
Oct-05-23 09:15AM
Oct-02-23 09:00AM
Sep-18-23 09:15AM
Sep-14-23 06:30AM
Sep-13-23 05:20PM
Sep-11-23 09:10AM
Sep-06-23 09:15AM
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kupiec James WilliamChief Medical OfficerNov 29 '24Sale3.874,00015,4800Dec 03 04:18 PM
Schoen EricChief Financial OfficerNov 29 '24Option Exercise1.1850,00059,00071,300Dec 03 04:16 PM
Schoen EricChief Financial OfficerNov 29 '24Sale3.8659,800230,82811,500Dec 03 04:16 PM
Schoen EricChief Financial OfficerNov 29 '24Sale3.822,0007,6400Dec 03 04:16 PM
Schoen, Eric J. (SAVA)OfficerNov 29 '24Proposed Sale3.822,0007,640Dec 02 05:14 PM
Schoen EricOfficerNov 29 '24Proposed Sale3.8659,800230,966Nov 29 03:33 PM